INHIBITION OF HCV REPLICATION BY CCR5 BLOCKADE WITH CENICRIVIROC AND MARAVIROC

被引：1
|
作者：
Sherman, K. E. [1 ]
Kong, L. [1 ]
Blackard, J. T. [1 ]
机构：
[1] Univ Cincinnati, Coll Med, Digest Dis, Cincinnati, OH USA
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)31109-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0906
引用
收藏
页码：S684 / S684
页数：1
相关论文
共 50 条
  • [1] Maraviroc: a new CCR5 antagonist
    Sayana, Shilpa
    Khanlou, Homayoon
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2009, 7 (01) : 9 - 19
  • [2] Future of maraviroc and other CCR5 antagonists
    Overton, E. Turner
    Powderly, William G.
    FUTURE VIROLOGY, 2006, 1 (05) : 605 - 613
  • [3] Treatment of HIV infection with the CCR5 antagonist maraviroc
    Kromdijk, Wiete
    Huitema, Alwin D. R.
    Mulder, Jan Willem
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (07) : 1215 - 1223
  • [4] Maraviroc - The first CCR5 antagonist for the treatment of HIV
    Girotto, Jennifer E.
    FORMULARY, 2007, 42 (10) : 601 - 608
  • [5] The role of CCR5 in HCV infection
    Martin Coenen
    Jacob Nattermann
    European Journal of Medical Research, 15
  • [6] THE ROLE OF CCR5 IN HCV INFECTION
    Coenen, Martin
    Nattermann, Jacob
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (03) : 97 - 101
  • [7] Binding of fusion protein FLSC IgG1 to CCR5 is enhanced by CCR5 antagonist Maraviroc
    Latinovic, Olga
    Szmacinski, Henryk
    Schneider, Kate
    Lakowicz, Joseph
    Heredia, Alonso
    Redfield, Robert
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 67 : 82 - 82
  • [8] Secondary effects of treatment with maraviroc and other CCR5 antagonists. Potential impact of the CCR5 blocker
    Arribas Lopez, Jose R.
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2008, 26 : 23 - 27
  • [9] Binding of fusion protein FLSC IgG1 to CCR5 is enhanced by CCR5 antagonist Maraviroc
    Latinovic, Olga
    Schneider, Kate
    Szmacinski, Henryk
    Lakowicz, Joseph R.
    Heredia, Alonso
    Redfield, Robert R.
    ANTIVIRAL RESEARCH, 2014, 112 : 80 - 90
  • [10] Maraviroc: A coreceptor CCR5 antagonist for management of HIV infection
    Yost, Raymond
    Pasquale, Timothy R.
    Sahloff, Eric G.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (08) : 715 - 726
12345